Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Eliquis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104341336B reveals a novel inorganic base route for Eliquis intermediates, offering significant cost reduction and enhanced supply chain reliability for pharmaceutical manufacturing.
Patent CN103342704B details improved Apixaban synthesis with higher yields. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN109956886A reveals high-purity Eliquis intermediate synthesis. Offers supply chain reliability and cost reduction in pharmaceutical manufacturing.